50
Participants
Start Date
April 30, 2005
Study Completion Date
August 31, 2006
CC-5013
gemcitabine
Charleston Cancer Center, Charleston
Case Western Reserve University Hospitals Ireland Cancer Center, Cleveland
Bernard Cancer Center, St Louis
Cancer and Blood Institute, Metairie
University of Texas MD Anderson Cancer Center, Houston
Sarah Cannon Cancer Center, Nashville
Lead Sponsor
Prologue Research International
INDUSTRY
Celgene Corporation
INDUSTRY